2009
DOI: 10.1038/sj.bjc.6605142
|View full text |Cite
|
Sign up to set email alerts
|

Isolation of tumour stem-like cells from benign tumours

Abstract: BACKGROUND: Cancerous stem-like cells (CSCs) have been implicated as cancer-initiating cells in a range of malignant tumours. Diverse genetic programs regulate CSC behaviours, and CSCs from glioblastoma patients are qualitatively distinct from each other. The intrinsic connection between the presence of CSCs and malignancy is unclear. We set out to test whether tumour stem-like cells can be identified from benign tumours. METHODS: Tumour sphere cultures were derived from hormone-positive and -negative pituitar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

10
121
2
1

Year Published

2009
2009
2017
2017

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 108 publications
(134 citation statements)
references
References 45 publications
(60 reference statements)
10
121
2
1
Order By: Relevance
“…In the present study, only NOTCH4, DLL1, and NESTIN were found to be overexpressed, with NOTCH4 and DLL1 being upregulated only in the total SP and not in the pSP. Moreover, expression levels of the multidrug transporter genes BCRP1 (ABCG2) and MDR1 (ABCB1) have been reported not to be upregulated in the PASCs (Xu et al 2009b). These divergent results could be mainly explained by the use of cultured cells (Xu et al 2009b) versus cells that were obtained directly from the tumor (the present study; further commented on in Vankelecom (2012) and Vankelecom & Chen (2014)).…”
Section: Discussioncontrasting
confidence: 41%
See 1 more Smart Citation
“…In the present study, only NOTCH4, DLL1, and NESTIN were found to be overexpressed, with NOTCH4 and DLL1 being upregulated only in the total SP and not in the pSP. Moreover, expression levels of the multidrug transporter genes BCRP1 (ABCG2) and MDR1 (ABCB1) have been reported not to be upregulated in the PASCs (Xu et al 2009b). These divergent results could be mainly explained by the use of cultured cells (Xu et al 2009b) versus cells that were obtained directly from the tumor (the present study; further commented on in Vankelecom (2012) and Vankelecom & Chen (2014)).…”
Section: Discussioncontrasting
confidence: 41%
“…Moreover, CXCR4 and PI3K/Akt are interconnected; it has been shown that the paracrine/autocrine activation of CXCR4 signaling provokes the Akt-mediated improvement in survival of glioblastoma CSCs (Rubin et al 2003, Gatti et al 2013. It should be noted that the expression pattern in the pSP only minimally overlaps with the set of genes (CD133, NESTIN, CD90/THY1, OCT4, MSI, JAG2, NOTCH4, and DLL1) that have recently been identified as being upregulated in candidate pituitary TSCs (so-called 'pituitary adenoma stem-like cells' (PASCs)), which were obtained by culture of sphere-like bodies (Xu et al 2009b). In the present study, only NOTCH4, DLL1, and NESTIN were found to be overexpressed, with NOTCH4 and DLL1 being upregulated only in the total SP and not in the pSP.…”
Section: Discussionmentioning
confidence: 99%
“…Xu et al (2009) reported the isolation of putative tumor-initiating cells from human pituitary adenomas. These clones were able to self-renew, had a differentiation potential for multiple pituitary cell lineages, expressed several stem/ progenitor-associated marker genes and initiated pituitary tumor formation after transplantation into immunodeficient mice.…”
Section: Introductionmentioning
confidence: 99%
“…TICs were initially identified in acute myeloid leukaemia (AML), and were found capable of inducing AML in immunodeficient mice (Lapidot et al, 1994;Bonnet and Dick, 1997). TICs have since been identified in numerous other tumours, including melanoma, lung, head, neck, pancreatic, prostate, colon, squamous cell cancers, and benign tumours (Collins et al, 2005;Fang et al, 2005;Kim et al, 2005;Dalerba et al, 2007;Prince et al, 2007;Loebinger et al, 2008;Xu et al, 2009). Although the AML TICs resemble and probably originate from the transformation of a stem cell, it is possible that other TICs originate from transformation of early or late progenitor cells.…”
mentioning
confidence: 99%